Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,765 | 4,745 | -4,920 | -48,832 | -43,789 |
| Depreciation Amortization | 3,008 | 1,893 | 825 | 2,681 | 2,013 |
| Accounts receivable | -8,347 | -6,534 | -7,484 | -21,994 | -24,999 |
| Accounts payable and accrued liabilities | 5,067 | 2,778 | 1,779 | -4,093 | -3,516 |
| Other Working Capital | -14,484 | -10,897 | -8,390 | -20,315 | -28,213 |
| Other Operating Activity | 36,661 | 12,480 | 9,958 | 45,646 | 43,724 |
| Operating Cash Flow | $26,670 | $4,465 | $-8,232 | $-46,907 | $-54,780 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 10,820 | 4,244 | 12,317 | 51,780 | 36,867 |
| PPE Investments | -190 | -181 | N/A | N/A | N/A |
| Other Investing Activity | -15,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-4,370 | $4,063 | $12,317 | $51,780 | $36,867 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,179 | 1,672 | 690 | 15,970 | 15,090 |
| Financing Cash Flow | $4,179 | $1,672 | $690 | $15,970 | $15,090 |
| Exchange Rate Effect | 1,963 | 1,831 | 224 | -639 | 238 |
| Beginning Cash Position | 51,371 | 51,371 | 51,371 | 31,167 | 31,167 |
| End Cash Position | 79,813 | 63,402 | 56,370 | 51,371 | 28,582 |
| Net Cash Flow | $28,442 | $12,031 | $4,999 | $20,204 | $-2,585 |
| Free Cash Flow | |||||
| Operating Cash Flow | 26,670 | 4,465 | -8,232 | -46,907 | -54,780 |
| Capital Expenditure | -190 | -181 | N/A | N/A | N/A |
| Free Cash Flow | 26,480 | 4,284 | -8,232 | -46,907 | -54,780 |